🇺🇸 FDA
Patent

US 10781218

Substituted inhibitors of menin-MLL and methods of use

granted A61PA61P35/00

Quick answer

US patent 10781218 (Substituted inhibitors of menin-MLL and methods of use) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00